Indeed, in lung cancer cells, simvastatin remodels TME and reverses epithelial-mesenchymal transition (EMT) by re-polarizing tumor-associated macrophages (TAMs) from M2 to M1 via cholesterol-associated LXR/ABCA1 regulation (Jin et al., 2019). The gene discussed is ABCA1; the disease is lung carcinoma.